Molecular therapy set to protect at-risk patients against heart attack and stroke

(Charit é - Universit ä tsmedizin Berlin) Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol -- one of the main risk factors for heart attack and stroke. This is the result of a clinical study that researchers from Charit é and Imperial College London have published as leading authors in the current edition of New England Journal of Medicine.
Source: EurekAlert! - Biology - Category: Biology Source Type: news